Clinical trial
Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in Brazil - CORALINE (LACOG 0625)
NCT07773285 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in Brazil - CORALINE (LACOG 0625)
- Lead sponsor
- Latin American Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2030
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic solid tumor, recurrent solid tumor, solid tumor